Medstar Health Research Institute
medstarhealth.orgTotal trials
157
Active
35
Phase 3
6
Total enrollment
29,397
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Rimegepant 75 MG | — | — | — | — | — | 1 | |
| Culturelle 10 Billion CFU | — | — | — | — | — | 2 | |
| Lactobacillus RhamnosusGG | — | — | — | — | — | 1 | |
| Saline bladder wash | — | — | — | — | — | 1 | |
| Bimatoprost | — | — | — | — | — | 1 | |
| Saline | — | — | — | — | — | 1 | |
| Lactobacillus Crispatus | — | — | — | — | — | 1 |
Next readouts
- 2024-12-30
- 2026-07-31
- 2026-09
- 2026-09
- 2027-03-30
Top conditions
- Cancer7
- Neurogenic Bladder6
- Coronary Artery Disease6
- Pelvic Organ Prolapse5
- Diabetes Mellitus4
- Breast Cancer4
- Heart Failure4
- Spinal Cord Injuries4
Frequently asked questions about Medstar Health Research Institute
- How many clinical trials does Medstar Health Research Institute have on ClinicalTrials.gov?
- Medstar Health Research Institute is listed as the lead sponsor on 157 clinical trials in ClinicalTrials.gov, 35 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Medstar Health Research Institute's trials are in Phase 3?
- 6 of Medstar Health Research Institute's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does Medstar Health Research Institute focus on?
- Medstar Health Research Institute's most-studied conditions on ClinicalTrials.gov are Cancer, Neurogenic Bladder, Coronary Artery Disease, Pelvic Organ Prolapse, Diabetes Mellitus.
- When are Medstar Health Research Institute's next clinical trial readouts?
- Medstar Health Research Institute has 5 upcoming primary-completion readouts tracked here; the soonest is “Treatment of Hypopigmented Scars With Bimatoprost”, expected around 2024-12-30.